GSK Q4 Earnings Fall, Sales Rise; 2025 Outlook Set

MT Newswires Live

Feb 05, 2025

GSK (GSK) reported Q4 earnings Wednesday of 0.23 British pounds ($0.29) per share, down from 0.29 pounds a year earlier.

An analyst polled by FactSet expected 0.20 pounds.

Sales for the quarter ended Dec. 31 were 8.12 billion pounds compared with 8.05 billion pounds a year earlier.

Analysts surveyed by FactSet estimated 7.78 billion.

GSK maintained its Q4 dividend at 0.16 pounds per share to be paid on April 10 to holders as of Feb. 21.

The company said it expects 2025 EPS to increase by 6% to 8% on sales growth of 3% to 5%. Analysts surveyed by FactSet estimate 1.55 pounds in core EPS on revenue of 31.10 billion pounds.

The company also approved a 2 billion pound share buyback program for the next 18 months.

Shares of the company were up over 5% in recent pre-market activity.

Price: 36.72, Change: +1.88, Percent Change: +5.40

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2509037184"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509037184\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509037184?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-05 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509037184","market":"fut","top_or_hot":-1,"title":"GSK Q4 Earnings Fall, Sales Rise; 2025 Outlook Set","media":"MT Newswires Live","content":"<html><body><p> GSK (GSK) reported Q4 earnings Wednesday of 0.23 British pounds ($0.29) per share, down from 0.29 pounds a year earlier.</p><p>An analyst polled by FactSet expected 0.20 pounds.</p><p>Sales for the quarter ended Dec. 31 were 8.12 billion pounds compared with 8.05 billion pounds a year earlier.</p><p>Analysts surveyed by FactSet estimated 7.78 billion.</p><p>GSK maintained its Q4 dividend at 0.16 pounds per share to be paid on April 10 to holders as of Feb. 21.</p><p>The company said it expects 2025 EPS to increase by 6% to 8% on sales growth of 3% to 5%. Analysts surveyed by FactSet estimate 1.55 pounds in core EPS on revenue of 31.10 billion pounds.</p><p>The company also approved a 2 billion pound share buyback program for the next 18 months.</p><p>Shares of the company were up over 5% in recent pre-market activity.</p><p>Price: 36.72, Change: +1.88, Percent Change: +5.40</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GSK Q4 Earnings Fall, Sales Rise; 2025 Outlook Set</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGSK Q4 Earnings Fall, Sales Rise; 2025 Outlook Set\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-05 18:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> GSK (GSK) reported Q4 earnings Wednesday of 0.23 British pounds ($0.29) per share, down from 0.29 pounds a year earlier.</p><p>An analyst polled by FactSet expected 0.20 pounds.</p><p>Sales for the quarter ended Dec. 31 were 8.12 billion pounds compared with 8.05 billion pounds a year earlier.</p><p>Analysts surveyed by FactSet estimated 7.78 billion.</p><p>GSK maintained its Q4 dividend at 0.16 pounds per share to be paid on April 10 to holders as of Feb. 21.</p><p>The company said it expects 2025 EPS to increase by 6% to 8% on sales growth of 3% to 5%. Analysts surveyed by FactSet estimate 1.55 pounds in core EPS on revenue of 31.10 billion pounds.</p><p>The company also approved a 2 billion pound share buyback program for the next 18 months.</p><p>Shares of the company were up over 5% in recent pre-market activity.</p><p>Price: 36.72, Change: +1.88, Percent Change: +5.40</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GSK","symbol_name":"葛兰素史克","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2509037184","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509037184","pubTimestamp":1738751186,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"GSK  reported Q4 earnings Wednesday of 0.23 British pounds  per share, down from 0.29 pounds a year earlier.An analyst polled by FactSet expected 0.20 pounds.Sales for the quarter ended Dec. 31 were 8.12 billion pounds compared with 8.05 billion pounds a year earlier.Analysts surveyed by FactSet estimated 7.78 billion.GSK maintained its Q4 dividend at 0.16 pounds per share to be paid on April 10 to holders as of Feb. 21.The company said it expects 2025 EPS to increase by 6% to 8% on sales growth of 3% to 5%. Analysts surveyed by FactSet estimate 1.55 pounds in core EPS on revenue of 31.10 billion pounds.The company also approved a 2 billion pound share buyback program for the next 18 months.Shares of the company were up over 5% in recent pre-market activity.Price: 36.72, Change: +1.88, Percent Change: +5.40","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"GSK":"葛兰素史克"},"translate_title":"葛兰素史克第四季度盈利下降，销售额上升；2025年展望集","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GSK":1},"content_text":"GSK (GSK) reported Q4 earnings Wednesday of 0.23 British pounds ($0.29) per share, down from 0.29 pounds a year earlier.An analyst polled by FactSet expected 0.20 pounds.Sales for the quarter ended Dec. 31 were 8.12 billion pounds compared with 8.05 billion pounds a year earlier.Analysts surveyed by FactSet estimated 7.78 billion.GSK maintained its Q4 dividend at 0.16 pounds per share to be paid on April 10 to holders as of Feb. 21.The company said it expects 2025 EPS to increase by 6% to 8% on sales growth of 3% to 5%. Analysts surveyed by FactSet estimate 1.55 pounds in core EPS on revenue of 31.10 billion pounds.The company also approved a 2 billion pound share buyback program for the next 18 months.Shares of the company were up over 5% in recent pre-market activity.Price: 36.72, Change: +1.88, Percent Change: +5.40","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}